Sponsor:
Mount Sinai Hospital, Canada
Code:
NCT06004739
Conditions
Infectious Disease
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
No Antibiotics for treatment of bacteriuria
Brief summary:
Conditions
Infectious Disease
Study ID
NCT06004739
Start date
May 18, 2024
Status verified date
Sep, 2024
Completion date
Sep, 2027
Anticipated
Primary completion date
Sep, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Enrollment
550 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
other: Antibiotics
other: No Antibiotics
Interventions
Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
No Antibiotics for treatment of bacteriuria
Primary outcome measure
Central contacts
Locations
Michael Garron Hospital
Recruiting
Toronto, Canada
Mount Sinai Hospital
Recruiting
Toronto, Canada
Sponsor
Mount Sinai Hospital, Canada
Last update posted
Sep 19, 2024
Last verified
Sep, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mount Sinai Hospital, Canada on 2024-09-19.